![](/img/cover-not-exists.png)
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
Kim, H R, Kang, H N, Shim, H S, Kim, E Y, Kim, J, Kim, D J, Lee, J G, Lee, C Y, Hong, M H, Kim, S-M, Kim, H, Pyo, K-H, Yun, M R, Park, H J, Han, J Y, Youn, H A, Ahn, M-J, Paik, S, Kim, T-M, Cho, B CLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx098
Date:
April, 2017
File:
PDF, 1.42 MB
english, 2017